Karen Knudsen: I am incredibly proud of what our team at the American Cancer Society accomplished in 2023

Karen Knudsen shared a post by American Cancer Society on LinkedIn:

“I am incredibly proud of what our team at the American Cancer Society accomplished in 2023, from awarding 100 new research and career development grants and launching ACS LION to our American Cancer Society Cancer Action Network (ACS CAN) team working to address gaps in cancer care by advocating for specific policies.

Learn more in our Annual Report.”

Quoting American Cancer Society’s post:

“We’ve been changing the course of cancer for more than 110 years. In 2023 alone, our impact includes providing more than 500,000 nights for free lodging for people with cancer and awarding researchers investigating promising cancer solutions with more than 100 grants. More in our Annual Report.”

Source: Karen Knudsen/LinkedIn and American Cancer Society/LinkedIn

Dr. Karen Knudsen is the Chief Executive Officer of the American Cancer Society and the American Cancer Society Action Network. She is also a member of the Board of Directors at Research!America.

Additionally, Dr. Knudsen serves on the Scientific Review Board at Genentech and has been a board member and as a member of the Board of Scientific Advisors at the National Cancer Institute (NCI). Dr. Knudsen is known for her practice-changing research in prostate cancer, which has contributed to new, effective cancer treatments.